| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,576 |
7,082 |
$403K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,560 |
2,893 |
$106K |
| 95923 |
|
1,107 |
1,081 |
$86K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,150 |
1,829 |
$80K |
| 95816 |
|
353 |
342 |
$76K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,260 |
3,099 |
$70K |
| 93922 |
|
1,362 |
1,089 |
$70K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
474 |
440 |
$32K |
| 95921 |
|
1,083 |
1,053 |
$30K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,095 |
1,020 |
$28K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
537 |
480 |
$23K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
306 |
282 |
$20K |
| 95930 |
|
342 |
330 |
$11K |
| 92653 |
|
303 |
295 |
$11K |
| 95957 |
|
355 |
340 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
542 |
494 |
$7K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
142 |
141 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,759 |
2,277 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
66 |
63 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
398 |
182 |
$5K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,213 |
1,852 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
717 |
687 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
95 |
91 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,488 |
1,183 |
$3K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
43 |
40 |
$3K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
220 |
138 |
$2K |
| 81003 |
|
996 |
790 |
$2K |
| 93000 |
|
149 |
133 |
$2K |
| 90732 |
|
12 |
12 |
$1K |
| 92585 |
|
18 |
17 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
18 |
18 |
$898.89 |
| 96138 |
|
354 |
339 |
$508.70 |
| 92551 |
|
378 |
347 |
$430.12 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
62 |
58 |
$392.00 |
| 90756 |
|
16 |
15 |
$251.10 |
| 90686 |
|
53 |
52 |
$179.30 |
| 90461 |
|
16 |
14 |
$106.97 |
| 3079F |
|
225 |
199 |
$0.00 |
| 3075F |
|
142 |
121 |
$0.00 |
| 3080F |
|
70 |
58 |
$0.00 |
| 3044F |
|
13 |
13 |
$0.00 |
| 3074F |
|
750 |
589 |
$0.00 |
| 99173 |
|
461 |
426 |
$0.00 |
| 3077F |
|
115 |
92 |
$0.00 |
| 3078F |
|
714 |
573 |
$0.00 |